News
Oval and SOLIZE enter into collaboration on injection device development
Press Release For Immediate Release Cambridge, UK. Monday, 28 April 2014 – Oval Medical Technologies Limited (“Oval”) Oval and SOLIZE enter into collaboration on injection device development. Working together to…
Read MoreTechnology Strategy Board – Smart Funding Award
Press Release For Immediate Release Oval Medical awarded Technology Strategy Board Smart funding award Cambridge, UK. 14 April 2014 – Oval Medical Technologies Limited (“Oval”) announced today they have received…
Read MoreOval’s technology features in Cambridge University paper exploring inclusive design
Inclusive design has unique challenges because it aims to improve usability for a wide range of users. This typically includes people with lower levels of ability, as well as mainstream…
Read MoreOval Medical secures £1 million deal with US pharmaceutical company
Oval Medical Technologies Ltd (‘Oval’) today announced that they have signed another deal following an initial feasibility study with a global pharmaceutical company, to a value in excess of one…
Read MoreOval Medical appoints new CEO
The board of Oval Medical Technologies Limited (‘Oval’) announces that effective from 1st May 2013, Barbara Lead has succeeded Dr Catherine Beech as Chief Executive Officer of Oval Medical Technologies…
Read MoreOval Medical announces the availability of functional prototypes
30th May 2013 – Oval Medical Technologies Ltd (‘Oval’), today have announced that functional prototypes of their autoinjector technology are now available. Oval’s specification for a standard 1ml device was…
Read MoreRevolutionary autoinjector pushes the limits of high viscosity drug delivery
17th April 2013 – Oval Medical Technologies Ltd (‘Oval’), today have announced that a variety of 1100 cPs solutions (the thickness of motor oil) have been successfully delivered through a…
Read MoreOval Medical receives ISO 13485:2012 certification for medical device development
21st February 2013 – Oval Medical Technologies Ltd (‘Oval’), the privately held autoinjector development company, today announced that is has been awarded BS EN ISO 13485:2012 certification. ISO 13485 is…
Read MoreOval Medical Technologies signs key agreement with leading global pharmaceutical company
May 14th, 2012 – Oval Medical Technologies Ltd. (“Oval”), the company developing the next generation of autoinjectors, today announced that they have entered into an agreement with a top ten…
Read MoreOval Medical collaborates with the Cambridge University MBA Venture Project
6th February 2012 – Cambridge-based Oval Medical Technologies Limited (“Oval Medical”) has recently collaborated on the Cambridge Venture Project (CVP), part of the MBA programme at the Judge Business School,…
Read More